myTomorrows

The cost of poor-fit referrals is paid in site staff time.  Last week we shared that most sites see a significant share of referrals ruled out before screening begins. So, what's driving that burden?  Our survey of 100 U.S. site professionals' points to two things:  → 27% of sites spend 20+ hours a week just reviewing incoming referrals.  → 52% use at least four different tools for pre-screening alone.  When referrals, data, and decisions are spread across too many places, friction builds at exactly the point where speed and accuracy matter most — and time that could go to patients goes to admin instead.  Better upstream qualification could change that.  Explore the full picture in The Referral Readiness Gap 👉 https://lnkd.in/eseQa5aw #ClinicalTrials #ClinicalResearch #TrialSites #ClinicalOperations 

More referrals don't always mean more progress. In a new myTomorrows survey of 100 U.S. clinical trial site professionals, 52% told us that at least 1 in 5 referrals are ruled ineligible before formal screening even begins. The reason? 62% say it's because patients simply don't meet key inclusion/exclusion criteria, meaning the referral was never a fit to begin with. It's a clear signal that recruitment's biggest challenge is no longer generating volume alone. It's readiness: whether patients arrive qualified, documented, and ready to move through enrollment. 📖 Our new report, The Referral Readiness Gap, explores what site teams are really up against — from hidden workload and fragmented systems to the support they say would make a difference. Read the full report findings 👉 https://lnkd.in/exbYDuKG Check out our blog: https://lnkd.in/eBk9EFAE #ClinicalTrials #ClinicalResearch #PatientRecruitment #ClinicalOperations

At myTomorrows we are passionate about making real change for the people who need it most.  Every day, we support patients and healthcare professionals in finding information and access to emerging therapies worldwide. Through a combination of AI-powered technology and human navigation, we make clinical trials and Expanded Access more accessible.  To help us scale our work even more, we’re looking for highly driven individuals to help us take myTomorrows to the next level.   We’re hiring:   - Product Marketing Manager (Amsterdam) https://lnkd.in/eHxiCi6a  - Product Marketing Manager (US) https://lnkd.in/etee84Ki  - Manager Real World Data (Amsterdam) https://lnkd.in/eu8qgRDD  - Regulatory Affairs Manager (US, Canada, UK) https://lnkd.in/egmWr4Pb  - Regulatory Affairs Manager (Amsterdam) https://lnkd.in/e4Cdqx3m    We support our employees in their career growth, while giving them the opportunity to solve complex challenges at the forefront of health tech and access.    You’ll experience:  - Project ownership and accountability   - Working patterns that suit you   - Continuous learning opportunities   - A collaborative team that respects one another    If this resonates with you, let’s talk  👉 Tag someone who should see this  #Hiring #NewRole #JobOpening #JobOpportunity #Recruiting 

At myTomorrows, we work every day to solve one of healthcare’s toughest challenges: helping patients access investigational medicines and clinical trials when time matters most.    If you thrive in high‑impact environments, love solving hard problems, and want your work to directly help patients and families around the world, you’ll love it here.    🚀 We are hiring:  - Applied AI Engineer - https://lnkd.in/ecgDCxAS  - Technical Product Owner - https://lnkd.in/eDvjEd-k  - Backend Engineer - https://lnkd.in/e-NP8PDY    ✨ What you’ll get at myTomorrows:  - Autonomy & trust  - Real flexibility  - Real flexibility  - A learning budget to fuel your growth  - A team united by a meaningful mission    If this mission resonates with you, let’s talk  👉 Tag someone who should see this  #Hiring #NewRole #JobOpening #JobOpportunity #Recruiting 

At myTomorrows we are passionate about making real change for the people who need it most.  Every day, we support patients and healthcare professionals in finding information and access to emerging therapies worldwide. Through a combination of AI-powered technology and human navigation, we make clinical trials and Expanded Access more  accessible.  To help us scale our work even more, we’re looking for highly driven individuals to help us take myTomorrows to the next level.   We’re hiring:   - Fullstack Engineer (Amsterdam) https://lnkd.in/eMiJwSA5 - Regulatory Affairs Manager (Amsterdam) https://lnkd.in/eiNb6Gec - Regulatory Affairs Manager (US, Canada, UK) https://lnkd.in/eifMdDi7 - Regulatory Affairs Director (Amsterdam) https://lnkd.in/eqam39pt - Regulatory Affairs Director (US, Canada, UK) https://lnkd.in/eg4w89cB We support our employees in their career growth, while giving them the opportunity to solve complex challenges at the forefront of health tech and access.    You’ll experience:  - Project ownership and accountability   - Working patterns that suit you   - Continuous learning opportunities   - A collaborative team that respects one another  If this resonates with you, let’s talk  👉 Tag someone who should see this  #Hiring #NewRole #JobOpening #JobOpportunity #Recruiting 

Our Product Mighties Bryan Berger & Filippo Frangioni representing at HLTH Europe this week 🙌

At this year’s DIA Global Annual meeting in Philadelphia next week, we will be holding the session “Who Owns Long-Term Follow-Up? Addressing Stakeholder Gaps in Gene Therapy Evidence Generation”. I will be moderating the discussion and alongside: - Pat Furlong: Founding President and CEO at Parent Project Muscular Dystrophy (PPMD) - Rafael Escandon, PhD, HEC-C: Founder- DG Bioethics - Carolyn Chapman PhD MS Independent Consultant; Faculty Affiliate at NYU Langone Section of Medical Ethics - Alen Agaronov: Independent Social Scientist As gene therapies continue to reshape the treatment landscape, the importance of clearly defining responsibility for long-term follow-up (LTFU) has never been greater. This session will dive into the evolving complexities of LTFU, exploring the operational, ethical, and evidentiary challenges that stakeholders face today, and how we can collectively move toward more sustainable, patient-centered approaches to long-term data collection and care.   Together with an exceptional group of panellists, we will discuss how industry, regulators, providers, and patient communities can better align to close critical gaps in evidence generation and ensure long-term outcomes are effectively captured and acted upon.   Please join us on Wednesday June 17th @ 4PM - Room 119 AB, for what promises to be a highly engaging and insightful discussion.   Looking forward to seeing you there!   #LTFU #GeneTherapy #DIA2026

At myTomorrows, we work every day to solve one of healthcare’s toughest challenges: helping patients access investigational medicines and clinical trials when time matters most.    If you thrive in high‑impact environments, love solving hard problems, and want your work to directly help patients and families around the world, you’ll love it here.  🚀 We are hiring:  - Legal Counsel Operations (Amsterdam): https://lnkd.in/eE6D8A9U - Backend Engineer (Amsterdam): https://lnkd.in/etRzYcER - Patient Navigator (China, South-Korea, Singapore or Australia): https://lnkd.in/ebPdZaWC ✨ What you’ll get at myTomorrows:  - Autonomy & trust  - Real flexibility  - A learning budget to fuel your growth - A team united by a meaningful mission    If this mission resonates with you, let’s talk  👉 Tag someone who should see this  #Hiring #NewRole #JobOpening #JobOpportunity #Recruiting 

🧠 No two brain tumor journeys are the same. For some people, a brain tumor diagnosis begins with headaches, vision changes, seizures, or balance problems. For others, the signs may be less obvious at first. And once a diagnosis is made, there can be many new things to understand: What type of tumor is it? What does the grade mean? How might it evolve? What treatment options may be available? Where can I find support? These questions can feel overwhelming, especially when information is hard to navigate or act on.   This World Brain Tumor Day, we want to help make some of that information easier to navigate, because when options aren’t clear or easy to find, they can feel out of reach. Our brain tumor resource page contains educational articles, support resources, and information about clinical trials, for patients, families, caregivers, and anyone looking to better understand the options that may be available Because when someone is facing a brain tumor, clear information matters. So does knowing where to start. 👉 Explore the myTomorrows brain tumor resource page. We have helped over 250 patients globally to get into clinical trials: https://lnkd.in/ezWYN6HF